Clinical Trial Update: Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update examining changes in bone metabolic markers and bone mineral density after denosumab and/or teriparatide in Japanese osteoporosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Shinshu University | Conditions: Osteoporosis | Phase 4 | Status: UNKNOWN